China SXT Pharmaceuticals (China SXT Pharmaceuticals) Buildings And Improvements : $0.34 Mil (As of Sep. 2023)

View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Buildings And Improvements?

China SXT Pharmaceuticals's quarterly buildings and improvements increased from Sep. 2022 ($0.00 Mil) to Mar. 2023 ($0.36 Mil) but then declined from Mar. 2023 ($0.36 Mil) to Sep. 2023 ($0.34 Mil).

China SXT Pharmaceuticals's annual buildings and improvements stayed the same from Mar. 2021 ($0.00 Mil) to Mar. 2022 ($0.00 Mil) but then increased from Mar. 2022 ($0.00 Mil) to Mar. 2023 ($0.36 Mil).

China SXT Pharmaceuticals Buildings And Improvements Historical Data

The historical data trend for China SXT Pharmaceuticals's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Buildings And Improvements Chart

China SXT Pharmaceuticals Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Buildings And Improvements

Get a 7-Day Free Trial

0.36

China SXT Pharmaceuticals Semi-Annual Data
	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Buildings And Improvements	Get a 7-Day Free Trial									-	-	-	0.36	0.34

China SXT Pharmaceuticals Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

China SXT Pharmaceuticals (China SXT Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

2RY0:Germany

Address

No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300

Website

http://www.sxtchina.com

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.